Medicine and Dentistry
In Vitro
100%
Myometrium
88%
Messenger RNA
81%
Neoplasm
71%
Uterus Contractility
69%
Cancer Stem Cell
59%
Umbilical Artery
55%
Rho Kinase
55%
Cancer Cell
55%
Premature Labor
38%
Vasoconstriction
37%
Isoprostane Derivative
37%
Circulating Tumor Cell
37%
Breast Cancer
37%
Ovarian Cancer
37%
Receptor
32%
Adrenergic Receptor
32%
Oxytocin
31%
Tumor Xenograft
28%
Uterine Cancer
26%
Placenta
25%
Scanning Electron Microscopy
25%
Cesarean Section
25%
Reverse Transcription Polymerase Chain Reaction
24%
Pre-Eclampsia
24%
Isometrics
23%
Cancer Growth
23%
Biopsy Technique
22%
Thrombin
22%
Solid Malignant Neoplasm
22%
Muscle Contractility
22%
Malignant Neoplasm
20%
Progesterone Receptor
20%
Cell Population
20%
Y-27632
19%
Ovarian Tumor
19%
Hydroxyprogesterone Caproate
18%
Proteinase Activated Receptor 4
18%
Hedgehog Signaling
18%
Endometrium Carcinoma
18%
Testis Biopsy
18%
Xenograft
18%
Exosome
18%
Artery Resistance
18%
Proteinase Activated Receptor 1
18%
Carcinogenicity
18%
Biopsy Sample
18%
Uterus Relaxation
18%
Endometrium Tumor
18%
Ritodrine
18%
Pharmacology, Toxicology and Pharmaceutical Science
Messenger RNA
71%
Neoplasm
67%
Oxytocin
45%
Premature Labor
44%
Thrombin
40%
Malignant Neoplasm
38%
Rho Kinase
37%
Ovary Cancer
37%
Scanning Electron Microscopy
31%
Proteinase Activated Receptor 1
31%
Phenylephrine
24%
Cancer Growth
23%
Breast Cancer
21%
Receptor
20%
Preeclampsia
20%
Hydroxyprogesterone Caproate
18%
Nucleic Acid
18%
Adenosine Triphosphate Sensitive Potassium Channel
18%
Liver Cancer
18%
Isoprostane Derivative
18%
Proteinase Activated Receptor 4
18%
Beta 2 Adrenergic Receptor Stimulating Agent
18%
Ritodrine
18%
Triple Negative Breast Cancer
18%
Protamine
18%
Endometrium Tumor
18%
Endometrium Cancer
18%
Carcinogenicity
18%
Prostate Cancer
18%
Isothiocyanate
18%
Hedgehog
18%
Cannabinoid
18%
Ovary Tumor
16%
Cannabinoid 2 Receptor
14%
8 Isoprostaglandin E2
13%
Adrenergic Receptor
13%
NOD SCID Mouse
11%
Nifedipine
11%
Cannabinoid 1 Receptor
11%
Flow Cytometry
11%
Tumor Growth
10%
Solid Malignant Neoplasm
9%
Rho Kinase Inhibitor
8%
Anandamide
7%
Endocannabinoid
7%
Tetrahydrocannabinol
7%
Proteinase Activated Receptor
6%
Competitive Antagonist
6%
Cyclopamine
6%
Cell Surface Marker
5%
Immunology and Microbiology
Myometrium
74%
Cancer Stem Cell
43%
Uterus Contractility
37%
Cancer Cell
37%
Cell Population
27%
Muscle Contractility
20%
NOD SCID Mouse
18%
Spermatogenesis
18%
ATP-Sensitive Potassium Channel
18%
Exosome
18%
Side Population Cell
18%
Promoter Region
18%
Methylation
18%
Labor Onset
15%
Smooth Muscle
12%
Immunofluorescence
12%
Endometrium
12%
Xenograft
12%
Scanning Electron Microscopy
12%
Endometrial Cancer Cell Line
12%
Agonist
9%
Stem Cell
9%
Cell Surface Marker
9%
Western Blot
7%
Protein Expression
6%
Antibodies
6%
Reverse Transcription Polymerase Chain Reaction
6%
Colon
6%
Lineages
6%
Pancreas
6%
Mouse Model
6%
Ovary
6%
Maximum Concentration
6%
Third Trimester Pregnancy
5%